Molecular US

MTEM NASDAQ
5.10
+0.04
+0.79%
Opening 12:36 08/19 EDT
Open
5.12
Prev Close
5.06
High
5.12
Low
5.00
Volume
14.23K
Avg Vol (3M)
112.68K
52 Week High
8.77
52 Week Low
3.190
% Turnover
0.04%
Market Cap
188.38M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Molecular US MTEM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies (ETBs). The Company is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. The Company’s lead drug candidate MT-3724 is an is an immunotoxin that targets the CD20 cell surface antigen present in a variety of lymphomas and leukemias.
MORE >

Recently

Name
Price
%Change